Elisa Dorantes-Acosta1, Diana Ávila-Montiel2, Miguel Klünder-Klünder3, Luis Juárez-Villegas4, Horacio Márquez-González2. 1. Biobanco de Investigación en Células Leucémicas. Hospital Infantil de México Federico Gómez, Mexico City, Mexico. 2. Investigación Clínica. Hospital Infantil de México Federico Gómez, Mexico City, Mexico. 3. Subdirección de Investigación. Hospital Infantil de México Federico Gómez, Mexico City, Mexico. 4. Departamento de Onco-Hematología. Hospital Infantil de México Federico Gómez, Mexico City, Mexico.
Abstract
Background: Coronavirus disease (COVID)-19 has currently affected 8,015,502 million people worldwide with global mortality around 5%. Information in pediatric cancer patients is still limited, but it is emerging day by day. The objective of this scoping review was to analyze the available data associated with COVID-19 infection and mortality in pediatric cancer patients and to provide useful information to plan and design strategies in this group. Methods: A search was conducted, and eight articles were obtained for qualitative analysis; 110 patients were included, all from cross-sectional studies. At the time of publication, all the analyzed documents reported no deaths associated with COVID-19. Results: According to the information, COVID-19 infection appears to be less severe in the pediatric population in comparison with adults and does not appear to be a cause of mortality in patients with childhood cancer. Conclusions: Given the nature of preliminary reports and a short follow-up in cancer patients, it is necessary to have medium- and long-term follow-up studies to determine the effects of infection and modifications to the treatments of these patients. Copyright:
Background: Coronavirus disease (COVID)-19 has currently affected 8,015,502 million people worldwide with global mortality around 5%. Information in pediatric cancerpatients is still limited, but it is emerging day by day. The objective of this scoping review was to analyze the available data associated with COVID-19infection and mortality in pediatric cancerpatients and to provide useful information to plan and design strategies in this group. Methods: A search was conducted, and eight articles were obtained for qualitative analysis; 110 patients were included, all from cross-sectional studies. At the time of publication, all the analyzed documents reported no deaths associated with COVID-19. Results: According to the information, COVID-19infection appears to be less severe in the pediatric population in comparison with adults and does not appear to be a cause of mortality in patients with childhood cancer. Conclusions: Given the nature of preliminary reports and a short follow-up in cancerpatients, it is necessary to have medium- and long-term follow-up studies to determine the effects of infection and modifications to the treatments of these patients. Copyright:
Authors: Rachel Harwood; Helen Yan; Nishanthi Talawila Da Camara; Clare Smith; Joseph Ward; Catrin Tudur-Smith; Michael Linney; Matthew Clark; Elizabeth Whittaker; Defne Saatci; Peter J Davis; Karen Luyt; Elizabeth S Draper; Simon E Kenny; Lorna K Fraser; Russell M Viner Journal: EClinicalMedicine Date: 2022-02-11
Authors: Amna Majeed; Tom Wright; Biqi Guo; Ramandeep S Arora; Catherine G Lam; Alexandra L Martiniuk Journal: Front Oncol Date: 2022-04-07 Impact factor: 5.738